Keith Grehan

Leeds, ENG LS29JT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Author Correction: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Author Correction: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Journal: NPJ vaccines

Published: May 29, 2026

Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.

Journal: NPJ vaccines

Published: November 07, 2024

Mechanism of enterovirus VP0 maturation cleavage based on the structure of a stabilised assembly intermediate.

Mechanism of enterovirus VP0 maturation cleavage based on the structure of a stabilised assembly intermediate.

Journal: PLoS pathogens

Published: May 07, 2024

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines.

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines.

Journal: Nature communications

Published: May 06, 2024

Mechanism of enterovirus VP0 maturation cleavage based on the structure of a stabilised assembly intermediate.

Mechanism of enterovirus VP0 maturation cleavage based on the structure of a stabilised assembly intermediate.

Journal: bioRxiv : the preprint server for biology

Published: April 15, 2024

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Journal: The Journal of general virology

Published: June 30, 2023

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

Journal: bioRxiv : the preprint server for biology

Published: February 13, 2023

VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein Display.

VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein Display.

Journal: mSphere

Published: January 31, 2023

Publisher Correction: A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.

Publisher Correction: A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.

Journal: Communications biology

Published: December 23, 2022

Protease-Independent Production of Poliovirus Virus-like Particles in Pichia pastoris: Implications for Efficient Vaccine Development and Insights into Capsid Assembly.

Protease-Independent Production of Poliovirus Virus-like Particles in Pichia pastoris: Implications for Efficient Vaccine Development and Insights into Capsid Assembly.

Journal: Microbiology spectrum

Published: December 12, 2022

Production and Characterisation of Stabilised PV-3 Virus-like Particles Using Pichia pastoris.

Production and Characterisation of Stabilised PV-3 Virus-like Particles Using Pichia pastoris.

Journal: Viruses

Published: August 16, 2022

A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.

A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.

Journal: Communications biology

Published: August 15, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026